by April Breyer Menon | Dec 28, 2020
Venable Fizpatrick partner Ha Kung Wong spoke with The Center for Biosimilars for an article reflecting on the biosimilar market in 2020 and what to expect in 2021, particularly with respect to the BPCIA, which is under review at the Supreme Court. The article by The...
by April Breyer Menon | Dec 23, 2020
On December 23, 2020, the PTAB sua sponte extended the pendency of Galderma v. Medy-Tox, PGR2019-00062, after determining good cause existed due to travel restrictions caused by the COVID-19 pandemic. The PGR involves U.S. Patent No. 10,143,728, titled “Long...
by April Breyer Menon | Dec 9, 2020
Download PDF Download...
by April Breyer Menon | Nov 30, 2020
Venable has released its annual statistical report on AIA trials before the USPTO’s Patent Trial and Appeal Board, including stats for IPRs, PGRs, and CBMs. The in-depth study analyzes the types of arguments that succeed more often than others and the trends...
by April Breyer Menon | Nov 9, 2020
Download PDF Download...